Education
About Us
Working with TipRanks
Follow Us
Abattis Bioceuticals (ATTBF)
:ATTBF
| Sep 19 | |
|---|---|
| Income Statement | |
| Total Revenue | C$ 356.88K |
| Gross Profit | C$ 241.34K |
| Operating Income | C$ -3.96M |
| EBITDA | C$ -3.85M |
| Net Income | C$ -3.04M |
| Balance Sheet | |
| Cash & Short-Term Investments | C$ 2.40M |
| Total Assets | C$ 19.26M |
| Total Debt | C$ 1.57M |
| Net Debt | C$ -449.84K |
| Total Liabilities | C$ 8.59M |
| Stockholders' Equity | C$ 11.08M |
| Cash Flow | |
| Free Cash Flow | C$ 4.35M |
| Operating Cash Flow | C$ 9.41M |
| Investing Cash Flow | C$ -11.52M |
| Financing Cash Flow | C$ 60.00K |
Abattis Bioceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.